• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    2/1/24 1:17:44 PM ET
    $AEY
    $AFL
    $ALGM
    $ASST
    Office Equipment/Supplies/Services
    Industrials
    Accident &Health Insurance
    Finance
    Get the next $AEY alert in real time by email

    Shares of C.H. Robinson Worldwide, Inc. (NASDAQ:CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.

    C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company’s quarterly sales came in at $4.20 billion versus estimates of $4.34 billion.

    C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Minim, Inc. (NASDAQ:MINM) shares climbed 57.3% to $6.45. David E. Lazar recently disclosed a 51% active stake in Minim.
    • Clearmind Medicine Inc. (NASDAQ:CMND) jumped 51% to $2.17. Clearmind Medicine announced long-term licensing agreement with BIRAD.
    • NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) climbed 52.9% to $5.00. NeuroBo Pharmaceuticals announced FDA clearance of IND for Phase 1 clinical trial of DA-1726 for the treatment of obesity.
    • FibroBiologics, Inc. (NASDAQ:FBLG) shares climbed 47.4% to $42.90. FibroBiologics announced direct listing on the NASDAQ.
    • Celularity Inc. (NASDAQ:CELU) rose 36% to $0.5191. Celularity said it sees FY24 net sales of $50 million to $56 million.
    • Cimpress plc (NASDAQ:CMPR) jumped 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares.
    • TuSimple Holdings Inc. (NASDAQ:TSP) rose 28% to $0.2950.
    • Elevai Labs, Inc. (NASDAQ:ELAB) gained 23.5% to $0.84 after gaining 8% on Wednesday.
    • Asset Entities Inc. (NASDAQ:ASST) climbed 22.8% to $0.5650.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares jumped 20.4% to $0.6649. Kiora Pharmaceuticals announced a private placement of up to $45 million.
    • Evaxion Biotech A/S (NASDAQ:EVAX) gained 19.5% to $4.70. Evaxion Biotech announced pricing of $15 million public offering of 3.750 million ADS at $4.00 per ADS.
    • Nextracker Inc. (NASDAQ:NXT) rose climbed 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results.
    • SunPower Corporation (NASDAQ:SPWR) jumped 18.1% to $3.5791.
    • BioRestorative Therapies, Inc. (NASDAQ:BRTX) gained 16.4% to $1.8850.
    • Corteva, Inc. (NYSE:CTVA) gained 16.2% to $52.84 after the company reported better-than-expected quarterly financial results, issued 2024 guidance and announced a $1 billion repurchase plan.
    • Nextracker Inc. (NYSE:NXT) jumped 16.1% to $52.56 after the company reported better-than-expected quarterly financial results.
    • Yoshiharu Global Co. (NASDAQ:YOSH) rose 15.9% to $5.10.
    • FuelCell Energy, Inc. (NASDAQ:FCEL) gained 15.7% to $1.3885.
    • Plug Power Inc. (NASDAQ:PLUG) climbed 12.2% to $4.9900. Plug Power said it completed first customer fill of liquid green hydrogen at its Georgia plant.
    • Credit Acceptance Corporation (NASDAQ:CACC) jumped 11.9% to $605.43 following upbeat earnings.
    • Digi International Inc. (NASDAQ:DGII) gained 11.7% to $27.17 following strong results.
    • Oragenics, Inc. (NYSE:OGEN) gained 11.1% to $2.5561 after dipping around 34% on Wednesday. Oragenics recently announced termination of at-market offering program.
    • Allegro MicroSystems, Inc. (NASDAQ:ALGM) climbed 10.9% to $28.77 following upbeat earnings.
    • Ferrari N.V. (NYSE:RACE) gained 10.4% to $382.17 after the company reported fourth-quarter financial results and issued 2024 guidance.
    • Etsy, Inc. (NASDAQ:ETSY) rose 9.6% to $72.95 after the company announced the appointment of Elliott Investment Management’s Marc Steinberg to its board.
    • Boot Barn Holdings, Inc. (NYSE:BOOT) gained 8.4% to $77.79 following upbeat earnings.
    • Sally Beauty Holdings, Inc. (NYSE:SBH) jumped 7.4% to $13.24 following upbeat earnings.
    • EverQuote, Inc. (NASDAQ:EVER) gained 7.2% to $13.53.
    • Deutsche Bank Aktiengesellschaft (NYSE:DB) shares gained 6.2% to $13.65 after the company posted fourth-quarter results and announced plans to cut 3,500 jobs. Deutsche Bank plans to increase both share repurchases and dividends by at least 50% year-over-year in 2024.

    Losers

    • Revelation Biosciences, Inc. (NASDAQ:REVB) shares dipped 61.1% to $3.4268 after the company announced pricing of $6.2 million public offering.
    • InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) fell 49% to $0.3267. InVivo Therapeutics Holdings and subsidiary filed for Chapter 11 bankruptcy in Delaware but plan to continue operating under court supervision as a debtor-in-possession.
    • Hesai Group (NASDAQ:HSAI) declined 28.2% to $4.1817. Hesai Group issued a statement on the U.S. Department of Defense "Chinese Military Companies" list.
    • FibroBiologics, Inc. (NASDAQ:FBLG) fell 27.4% to $21.12.
    • Volcon, Inc. (NASDAQ:VLCN) shares dipped 24.3% to $0.1020 after the company announced a 1-for-45 reverse stock split.
    • Peloton Interactive, Inc. (NASDAQ:PTON) fell 22.9% to $4.2850 after the company reported mixed second-quarter financial results and issued third-quarter revenue guidance below estimates.
    • CareMax, Inc. (NASDAQ:CMAX) fell 21.4% to $8.10.
    • ADDvantage Technologies Group, Inc. (NASDAQ:AEY) shares declined 21.3% to $1.4320.
    • Earlyworks Co., Ltd (NASDAQ:ELWS) fell 21.2% to $0.44 after surging more than 55% on Wednesday.
    • Infobird Co., Ltd (NASDAQ:IFBD) shares declined 20.6% to $1.0799 after surging over 115% on Wednesday.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) fell 19.3% to $2.0410.
    • Rocket Lab USA, Inc. (NASDAQ:RKLB) shares declined 18.7% to $3.9450 after the company announced a proposed offering of $275 million convertible senior notes.
    • Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) fell 18.4% to $3.9736 after declining 9% on Wednesday. Bullfrog AI Holdings recently filed shelf offering of 786,938 shares and accompanying warrants at $6.63 per share and accompanying warrant.
    • Thermon Group Holdings, Inc. (NYSE:THR) fell 16.2% to $27.45 following third-quarter results.
    • Polestar Automotive Holding UK PLC (NASDAQ:PSNY) declined 15.9% to $1.8250 after Volvo Cars said it will no longer provide further funding to the company.
    • Surmodics, Inc. (NASDAQ:SRDX) fell 14.9% to $29.97 following first-quarter results.
    • MaxLinear, Inc. (NYSE:MXL) shares dipped 14.4% to $17.83 after reporting fourth-quarter results.
    • 8x8, Inc. (NASDAQ:EGHT) fell 13.5% to $2.9050 following weak sales.
    • New York Community Bancorp, Inc. (NYSE:NYCB) dipped 13.5% to $5.60 after multiple firms downgraded the stock following the company's fourth-quarter results.
    • IHS Holding Limited (NYSE:IHS) fell 11.9% to $3.5050.
    • Western Alliance Bancorporation (NYSE:WAL) dipped 10% to $57.58.
    • Aflac Incorporated (NYSE:AFL) shares declined 9.7% to $76.17 after the company reported worse-than-expected fourth-quarter financial results.
    • Markel Group Inc. (NYSE:MKL) dipped 9.4% to $1,356.53 after the company reported 2023 financial results.
    • Wolfspeed, Inc. (NYSE:WOLF) shares fell 9.2% to $29.56 following the company's second-quarter earnings.
    • Valley National Bancorp (NASDAQ:VLY) dipped 8% to $8.85.
    • Zions Bancorporation, National Association (NASDAQ:ZION) fell 6.6% to $39.12.
    • ING Groep N.V. (NYSE:ING) shares declined 5.9% to $13.37 following fourth-quarter results.
    • Sanofi (NASDAQ:SNY) fell 3.2% to $48.33 after the company posted fourth-quarter results and named François-Xavier Roger as Chief Financial Officer.

     

    Now Read This: Bitcoin Falls Following Jobless Claims Data; Jupiter, FTX Token Among Top Losers

    Get the next $AEY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEY
    $AFL
    $ALGM
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    Western Alliance Bancorporation
    $WAL
    3/9/2026$83.00Buy → Hold
    TD Cowen
    Zions Bancorporation N.A.
    $ZION
    3/9/2026$65.00Neutral → Outperform
    Robert W. Baird
    Western Alliance Bancorporation
    $WAL
    3/9/2026$79.00Underweight → Equal Weight
    Wells Fargo
    Zions Bancorporation N.A.
    $ZION
    3/2/2026$75.00Equal-Weight → Overweight
    Morgan Stanley
    Etsy Inc.
    $ETSY
    2/20/2026$72.00Equal Weight → Overweight
    Barclays
    Evaxion A/S
    $EVAX
    2/19/2026$10.00Buy
    Maxim Group
    Polestar Automotive Holding UK PLC
    $PSNY
    2/19/2026Neutral → Underweight
    Cantor Fitzgerald
    Allegro MicroSystems Inc.
    $ALGM
    2/13/2026$51.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $AEY
    $AFL
    $ALGM
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Western Alliance Bancorp downgraded by TD Cowen with a new price target

    TD Cowen downgraded Western Alliance Bancorp from Buy to Hold and set a new price target of $83.00

    3/9/26 9:01:09 AM ET
    $WAL
    Major Banks
    Finance

    Zions Bancorp upgraded by Robert W. Baird with a new price target

    Robert W. Baird upgraded Zions Bancorp from Neutral to Outperform and set a new price target of $65.00

    3/9/26 8:45:59 AM ET
    $ZION
    Major Banks
    Finance

    Western Alliance Bancorp upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Western Alliance Bancorp from Underweight to Equal Weight and set a new price target of $79.00

    3/9/26 8:45:28 AM ET
    $WAL
    Major Banks
    Finance

    $AEY
    $AFL
    $ALGM
    $ASST
    SEC Filings

    View All

    SEC Form S-1 filed by Wolfspeed Inc.

    S-1 - WOLFSPEED, INC. (0000895419) (Filer)

    3/9/26 4:51:16 PM ET
    $WOLF
    Semiconductors
    Technology

    SEC Form 424B3 filed by Wolfspeed Inc.

    424B3 - WOLFSPEED, INC. (0000895419) (Filer)

    3/9/26 4:33:29 PM ET
    $WOLF
    Semiconductors
    Technology

    SEC Form 8-K filed by Wolfspeed Inc.

    8-K - WOLFSPEED, INC. (0000895419) (Filer)

    3/9/26 4:26:43 PM ET
    $WOLF
    Semiconductors
    Technology

    $AEY
    $AFL
    $ALGM
    $ASST
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

    Submission status for SANOFI-AVENTIS US's drug SOLIQUA 100/33 (SUPPL-14) with active ingredient INSULIN GLARGINE; LIXISENATIDE has changed to 'Approval' on 11/01/2024. Application Category: BLA, Application Number: 208673, Application Classification:

    11/4/24 4:49:34 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEY
    $AFL
    $ALGM
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Simmons Harris H bought $265,635 worth of shares (4,500 units at $59.03), increasing direct ownership by 0.34% to 1,317,493 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    2/25/26 4:33:19 PM ET
    $ZION
    Major Banks
    Finance

    Chief Financial Officer Pham Benjamin bought $115,095 worth of shares (14,114 units at $8.15) (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    2/19/26 8:00:23 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Director Vazquez Carlos J bought $33,612 worth of shares (2,500 units at $13.45), increasing direct ownership by 143% to 4,252 units (SEC Form 4)

    4 - VALLEY NATIONAL BANCORP (0000714310) (Issuer)

    2/18/26 9:04:16 AM ET
    $VLY
    Major Banks
    Finance

    $AEY
    $AFL
    $ALGM
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Shugar Daniel S sold $6,253,223 worth of shares (59,456 units at $105.17), decreasing direct ownership by 7% to 746,339 units (SEC Form 4)

    4 - Nextpower Inc. (0001852131) (Issuer)

    3/9/26 9:00:02 PM ET
    $NXT
    Industrial Machinery/Components
    Industrials

    Director Saintil Merline sold $1,360,171 worth of shares (18,126 units at $75.04), decreasing direct ownership by 6% to 261,903 units (SEC Form 4)

    4 - Rocket Lab Corp (0001819994) (Issuer)

    3/9/26 8:06:01 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Executive Vice President Stephens Steven Dan covered exercise/tax liability with 95 shares, decreasing direct ownership by 0.20% to 48,105 units (SEC Form 4)

    4 - ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (0000109380) (Issuer)

    3/9/26 4:41:01 PM ET
    $ZION
    Major Banks
    Finance

    $AEY
    $AFL
    $ALGM
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MaxLinear, Inc. Announces Upcoming Financial Conference Participation

    MaxLinear, Inc. (NASDAQ:MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced that it will participate in the following upcoming financial conferences: Cantor Tech and Industrial Growth Conference in New York City on March 11th at 9:20 am ET. A webcast of the session will be available at https://investors.maxlinear.com. 38th Annual Roth Capital Conference in Dana Point, Calif. on March 23rd. About MaxLinear, Inc. MaxLinear, Inc. (NASDAQ:MXL) is a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industr

    3/9/26 4:35:00 PM ET
    $MXL
    Semiconductors
    Technology

    FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

    Maranello (Italy), March 9 2026 – Ferrari N.V. (NYSE/EXM: RACE) ("Ferrari" or the "Company") informs that the Company has purchased, under the Euro 250 million share buyback program announced on December 16, 2025, as the first tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the "First Tranche"), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) and on the New York Stock Exchange (NYSE) as follows:  EXMNYSETotalTradingNumber of common shares purchasedAverage price per shareConsideration excluding feesNum

    3/9/26 1:22:23 PM ET
    $RACE
    Auto Manufacturing
    Industrials

    Sally Beauty Introduces COLORfest: A New Campaign of Self-Expression and Transformation through Color

    COLORfest is a month-long celebration of hair and nail color across Sally Beauty stores and online nationwide — headlined by an immersive pop-up experience in Los AngelesPLANO, Texas, March 9, 2026 /PRNewswire/ -- Sally Beauty, the industry-leading destination for professional-quality hair color, hair care, and nails, announces the launch of COLORfest, a month-long celebration of hair and nail color that brings together immersive experiences, expert guidance, and curated product offerings. As part of the campaign, Sally Beauty will debut an immersive, free-to-attend pop-up event on Saturday, Mar. 14 at The Grove in Los Angeles from 10:00 a.m. to 10:00 p.m. PST. The experience invites beauty

    3/9/26 9:02:00 AM ET
    $SBH
    Other Specialty Stores
    Consumer Discretionary

    $AEY
    $AFL
    $ALGM
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    Plug Power Welcomes Jose Luis Crespo as Chief Executive Officer

    SLINGERLANDS, N.Y., March 03, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions, welcomes Jose Luis Crespo as Chief Executive Officer, marking the start of the Company's next phase of disciplined growth and focused execution. Crespo assumed the role on March 2, 2026. Crespo brings more than 12 years of leadership experience at Plug, most recently serving as President and Chief Revenue Officer, where he drove growth through cost discipline, margin expansion, and capital efficiency. He led Plug's commercial organization during a period of significant scale, helping grow revenue from approximately $27 million in 2013 to more than $700

    3/3/26 7:00:00 AM ET
    $PLUG
    Industrial Machinery/Components
    Energy

    Polestar starts largest model offensive in its history: four new cars in three years

    Polestar 5 to start deliveries in summer, followed by a new variant of Polestar 4 in Q4 of 2026 Completely new successor of the iconic Polestar 2 in 2027 and compact SUV Polestar 7 in 2028 Michael Lohscheller, Polestar CEO: "Polestar continues to challenge the automotive industry, now by entering fast-growing and high value segments in record speed." Polestar (NASDAQ:PSNY) today announced the largest model offensive in its history, with four new cars planned in the next three years. The Company also announced that with a disciplined approach, in 2026 it expects low double-digit volume growth and a continued retail network expansion of 30%. This press release features multimedia.

    2/18/26 6:00:00 AM ET
    $PSNY
    Auto Manufacturing
    Industrials

    Sanofi announces leadership evolution in Specialty Care Business Unit

    CAMBRIDGE, Mass., Feb. 17, 2026 /PRNewswire/ -- Sanofi today announced the appointment of Manuela Buxo as Head of Specialty Care, effective March 1, 2026. Manuela will succeed Brian Foard, who has decided to leave the company as of February 28, 2026, having accepted an external leadership opportunity. Brian joined Sanofi in 2017 and has held several senior leadership roles, most recently leading the Specialty Care Global Business Unit and serving as a member of the Executive Committee. During his tenure, Sanofi's Specialty Care strengthened its global position, driven by the launches of key medicines such as Dupixent across multiple indications and geographies. Manuela will lead Sanofi's Spe

    2/17/26 8:30:00 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEY
    $AFL
    $ALGM
    $ASST
    Financials

    Live finance-specific insights

    View All

    Western Alliance Bancorporation Takes Decisive Action on LAM Trade Finance Loan

    Complaint Filed this Morning, Initiating Legal Action to Collect Amount Owed Charging-Off Remaining LAM I Loan Balance of $126.4 Million Financial Impact Substantially Mitigated Through Realization of Securities Sale Gains & Expense Reductions Western Alliance Bancorporation (the "Company") today announced that it has been informed by Jefferies Financial Group ("Jefferies") that payments of $126.4 million owed to Western Alliance Bank ("Bank") pursuant to a forbearance agreement will not be paid as agreed. Earlier this morning, the Bank and its Collateral Agent filed a Complaint in New York Supreme Court against Jefferies, Leucadia Asset Management LLC ("LAM"), and affiliates (c

    3/6/26 7:33:00 AM ET
    $WAL
    Major Banks
    Finance

    Evaxion plans to file 2025 annual report later today

    COPENHAGEN, Denmark, March 5, 2026 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will slightly delay the filing and publication of its 2025 annual report, planned before opening of Nasdaq CM today, due to unforeseen technical issues with external vendors.   The report has been finalized as planned and will be filed and published as soon as possible. The technical issues relate to regulatory filing demands and have nothing to do with the report itself.  As a consequence of the technical delay, the conference call and webcast planned for today will be moved to tomorrow: Friday March 6 at 8.30 E

    3/5/26 8:02:13 AM ET
    $EVAX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Hesai Group to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, March 24, 2026

    SHANGHAI, China, March 04, 2026 (GLOBE NEWSWIRE) -- Hesai Group ("Hesai," "Hesai Technology" or the "Company") (NASDAQ:HSAI, HKEX: 2525)), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced that it will report its fourth quarter and full year 2025 unaudited financial results on Tuesday, March 24, 2026, before the U.S. market opens. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 24, 2026 (8:00 PM Beijing/Hong Kong Time on March 24, 2026). For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration and dial in 5 minutes pri

    3/4/26 3:30:00 AM ET
    $HSAI
    Industrial Machinery/Components
    Industrials

    $AEY
    $AFL
    $ALGM
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Wolfspeed Inc.

    SC 13G/A - WOLFSPEED, INC. (0000895419) (Subject)

    12/6/24 11:56:48 AM ET
    $WOLF
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by Thermon Group Holdings Inc.

    SC 13G/A - Thermon Group Holdings, Inc. (0001489096) (Subject)

    12/6/24 10:11:20 AM ET
    $THR
    Industrial Machinery/Components
    Energy

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials